Endo International plc

ENDPQ

IE00BJ3V9050

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:42:21 2024-04-18 pm EDT			5-day change	1st Jan Change
0.0006 ^USD	0.00%		+100.00%	+20.00%

Mar. 22	Fourth Amended Joint Reorganization Plan Approved for Endo International plc	CI
Mar. 20	Health Care Down on Rate Bias -- Health Care Roundup	DJ

Endo International plc(NasdaqGS:ENDP) dropped from Russell 2000 Growth Index

June 25, 2021 at 12:00 am EDT

Latest news about Endo International plc

Fourth Amended Joint Reorganization Plan Approved for Endo International plc	Mar. 22	CI
Health Care Down on Rate Bias -- Health Care Roundup	Mar. 20	DJ
News Highlights : Top Company News of the Day - Wednesday at 5 PM ET	Mar. 20	DJ
Drugmaker Endo receives US court approval for bankruptcy restructuring	Mar. 19	RE
Drugmaker Endo receives US court approval for bankruptcy restructuring, Bloomberg News reports	Mar. 19	RE
Fourth Amended Joint Reorganization Plan Filed by Endo International plc	Mar. 18	CI
North American Morning Briefing : Stock Futures -2-	Mar. 11	DJ
Health Care Flat After Trial Setbacks -- Health Care Roundup	Mar. 08	DJ
Endo International plc Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Endo International plc Reports Property, Plant and Equipment Impairment Charges for the Three Months Ended December 31, 2023	Mar. 06	CI
Endo International plc Provides Earnings Guidance for the Year 2024	Mar. 06	CI
Endo International plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Drugmaker Endo reaches $465 mln bankruptcy settlement with US	Feb. 29	RE
Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	Feb. 20	CI
Motion for Exclusivity Period Extension Approved For Endo International plc	Jan. 24	CI
News Highlights : Top Energy News of the Day - Friday at 4 PM ET	Jan. 12	DJ
News Highlights : Top Energy News of the Day - Friday at 11 AM ET	Jan. 12	DJ
News Highlights : Top Energy News of the Day - Friday at 7 AM ET	Jan. 12	DJ
News Highlights : Top Energy News of the Day - Friday at 4 AM ET	Jan. 12	DJ
News Highlights : Top Energy News of the Day - Friday at 12 AM ET	Jan. 12	DJ
Combined Hearing for Disclosure Statement and Plan Approved for Endo International plc	Jan. 12	CI
News Highlights : Top Energy News of the Day - Thursday at 4 PM ET	Jan. 11	DJ
News Highlights : Top Energy News of the Day - Thursday at 11 AM ET	Jan. 11	DJ
News Highlights : Top Energy News of the Day - Thursday at 7 AM ET	Jan. 11	DJ
News Highlights : Top Energy News of the Day - Thursday at 4 AM ET	Jan. 11	DJ

Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL and EDEX, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The Companyâs Generic Pharmaceuticals segment consists of a product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ENDO INTERNATIONAL PLC	+20.00%	141K
ELI LILLY AND COMPANY	+27.97%	672B
NOVO NORDISK A/S	+23.36%	550B
JOHNSON & JOHNSON	-7.02%	351B
MERCK & CO., INC.	+14.85%	317B
ABBVIE INC.	+6.25%	292B
ASTRAZENECA PLC	+1.91%	211B
NOVARTIS AG	-0.68%	203B
ROCHE HOLDING AG	-10.35%	194B
PFIZER, INC.	-11.81%	144B

Other Pharmaceuticals